Researchers from North Carolina State University have discovered that a particular molecular signaling pathway plays an important role in producing osteoarthritis (OA) pain. Using a mouse model of painful osteoarthritis, ...
Jan 27, 2022
0
107
Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?
Dec 18, 2021
0
350
Research led by the University of Tübingen, Germany, along with partners at Stanford University, Emory University and the Cincinnati Children's Hospital Medical Center, U.S., has looked into infant immune responses following ...
A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
Sep 22, 2022
0
130
The most complete picture yet is shedding light on how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, ...
May 4, 2021
0
267
The rare blood clot side-effect associated with some COVID-19 vaccines could be the result of genetics, new research has found, paving the way for a potential genetic screening test.
Apr 11, 2022
0
185
A team of researchers at the U.S. National Institutes of Health, working with colleagues from Emory University School of Medicine, Emmes Company, Moderna, Inc. and Kaiser Permanente Washington Health Research Institute, has ...
Hope for a future without fear of COVID-19 comes down to circulating antibodies and memory B cells. Unlike circulating antibodies, which peak soon after vaccination or infection only to fade a few months later, memory B cells ...
Aug 24, 2021
0
1941
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University ...
May 24, 2021
2
2692
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold ...
May 17, 2021
1
934
